NCT06554132View on ClinicalTrials.gov

Respiratory Muscle Strength and Aerobic Capacity in Scleroderma

RecruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

October 20, 2024

Study Completion Date

October 30, 2024

Conditions
Scleroderma
Interventions
OTHER

Scleroderma Group

Scleroderma patients will be evaluated in terms of respiratory muscle strength, aerobic capacity, pulmonary function test and fatigue.

OTHER

Healthy group

Healthy people will be evaluated in terms of respiratory muscle strength, aerobic capacity, pulmonary function test and fatigue.

Trial Locations (1)

23100

RECRUITING

Songul Baglan Yentur, Elâzığ

All Listed Sponsors
lead

Firat University

OTHER